EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C14H17N3O9 |
| Net Charge | 0 |
| Average Mass | 371.302 |
| Monoisotopic Mass | 371.09648 |
| SMILES | CC(=O)OC[C@H]1O[C@@H](n2ncc(=O)nc2=O)[C@H](OC(C)=O)[C@@H]1OC(C)=O |
| InChI | InChI=1S/C14H17N3O9/c1-6(18)23-5-9-11(24-7(2)19)12(25-8(3)20)13(26-9)17-14(22)16-10(21)4-15-17/h4,9,11-13H,5H2,1-3H3,(H,16,21,22)/t9-,11-,12-,13-/m1/s1 |
| InChIKey | QQOBRRFOVWGIMD-OJAKKHQRSA-N |
| Species of Metabolite | Component | Source | Comments |
|---|---|---|---|
| Bacillus methanolicus MGA3 (ncbitaxon:796606) | |||
| - | PubMed (26366644) | ||
| - | MetaboLights (MTBLS228) |
| Roles Classification |
|---|
| Applications: | antipsoriatic A drug used to treat psoriasis. prodrug A compound that, on administration, must undergo chemical conversion by metabolic processes before becoming the pharmacologically active drug for which it is a prodrug. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| azaribine (CHEBI:88272) has functional parent 6-azauridine (CHEBI:35668) |
| azaribine (CHEBI:88272) has role antipsoriatic (CHEBI:50748) |
| azaribine (CHEBI:88272) has role prodrug (CHEBI:50266) |
| azaribine (CHEBI:88272) is a N-glycosyl-1,2,4-triazine (CHEBI:48018) |
| azaribine (CHEBI:88272) is a acetate ester (CHEBI:47622) |
| IUPAC Name |
|---|
| 2-(2,3,5-tri-O-acetyl-β-D-ribofuranosyl)-1,2,4-triazine-3,5(2H,4H)-dione |
| INNs | Source |
|---|---|
| azaribine | ChemIDplus |
| azaribina | ChemIDplus |
| azaribinum | ChemIDplus |
| Synonyms | Source |
|---|---|
| 2-(2',3',5'-Triacetyl-beta-D-ribofuranosyl)-as-triazine-3,5-(2H,4H)-dione | ChemIDplus |
| Triacetyl-6-azauridine | ChemIDplus |
| 2-beta-D-Ribofuranosyl-as-triazine-3,5(2H,4H)-dione 2',3',5'-triacetate | ChemIDplus |
| 6-Azauridine 2',3',5'-triacetate | ChemIDplus |
| 2',3',5'-Tri-O-acetyl-6-azauridine | ChemIDplus |
| 2',3',5'-Triacetyl-6-azauridine | ChemIDplus |
| Brand Name | Source |
|---|---|
| Triazure | KEGG DRUG |
| Citations |
|---|